EMBASSY ACQUISITION CORP. FORM 8-K 10/30/97

Company

Protalix BioTherapeutics, Inc.

Filed

November 10, 1997

Period of Report

October 30, 1997

Accession Number

0000950144-97-011740

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →